We are live on ! Find out more
TD Asset Management

TD Asset Management Portfolio holdings

AUM $123B
1-Year Est. Return 34.51%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$82.9B
AUM Growth
+$1.82B
Cap. Flow
-$3.2B
Cap. Flow %
-3.86%
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76

Sector Composition

Rank Sector Weight
1 Technology 19.76%
2 Financials 19.43%
3 Healthcare 10.94%
4 Consumer Discretionary 8.03%
5 Communication Services 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPID icon
1401
Rapid Micro Biosystems
RPID
$106M
$76.6K ﹤0.01%
58,496
-58,688
-50% -$76.2K
NOK icon
1402
Nokia
NOK
$51B
$76.1K ﹤0.01%
15,489
+16
+0.1% +$75
ALEC icon
1403
Alector
ALEC
$168M
$69.8K ﹤0.01%
11,269
-21,700
-66% -$177K
MUFG icon
1404
Mitsubishi UFJ Financial
MUFG
$253B
$65.2K ﹤0.01%
+10,209
New +$71.4K
LCAAW
1405
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$41.7K ﹤0.01%
83,333
-83,333
-50% -$33.8K
GOSS icon
1406
Gossamer Bio
GOSS
$82.9M
$32.3K ﹤0.01%
25,667
-8,133
-24% -$15.6K
APGB.WS
1407
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$29.3K ﹤0.01%
300,000
NFNT.WS
1408
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$28.3K ﹤0.01%
157,500
RLMD icon
1409
Relmada Therapeutics
RLMD
$557M
$28.3K ﹤0.01%
12,500
ALLG.WS
1410
DELISTED
Allego N.V. Warrants
ALLG.WS
$24.8K ﹤0.01%
100,000
PNTM.WS
1411
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$20K ﹤0.01%
116,667
-116,666
-50% -$25.6K
JWSM.WS
1412
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$19K ﹤0.01%
175,000
BLEUR
1413
DELISTED
bleuacacia ltd Rights
BLEUR
$17.6K ﹤0.01%
450,000
SONDW
1414
DELISTED
Sonder Holdings Inc Warrants
SONDW
$13K ﹤0.01%
180,000
FRC
1415
DELISTED
First Republic Bank
FRC
$8.82K ﹤0.01%
63,036
+2,273
+4% +$233K
WAVC.WS
1416
DELISTED
Waverley Capital Acquisition Corp. 1 Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
WAVC.WS
$8.13K ﹤0.01%
83,333
CVIIW
1417
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$7.35K ﹤0.01%
60,000
BLEUW
1418
DELISTED
bleuacacia ltd Warrants
BLEUW
$6.43K ﹤0.01%
225,000
HCNEW
1419
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
$6.19K ﹤0.01%
37,500
PRPC.WS
1420
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$6.1K ﹤0.01%
30,000
VEEAW
1421
Veea Inc Warrant
VEEAW
$3.8K ﹤0.01%
20,000
EQRXW
1422
DELISTED
EQRx, Inc. Warrant
EQRXW
$3.69K ﹤0.01%
20,318
CCVI.WS
1423
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$1.1K ﹤0.01%
10,000
WGSWW
1424
DELISTED
GeneDx Holdings Warrant
WGSWW
$323 ﹤0.01%
17,442
APAM icon
1425
Artisan Partners
APAM
$2.79B
-752,431
Closed -$22.3M

Similar funds

TD Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.

  • TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
  • TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
  • TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
  • TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
  • TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
  • TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
  • TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.

Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.